← PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $90.7m |
$93.5m
+3.04%
|
$78.6m
-15.88%
|
$90.9m
+15.60%
|
$78.9m
-13.20%
|
$130.5m
+65.43%
|
$128.3m
-1.69%
|
$200.5m
+56.29%
|
$154.0m
-23.19%
|
$160.0m
+3.89%
|
$159.3m
-0.46%
|
|
| Other Cost of Operating Revenue | $12.0m | $15.9m | — | — | — | — | — | — | — | — | — | |
| Cost of Revenue | $46.6m |
$58.8m
+26.32%
|
$53.5m
-8.98%
|
$56.3m
+5.20%
|
$46.3m
-17.74%
|
$71.7m
+54.67%
|
$79.3m
+10.63%
|
$147.7m
+86.38%
|
$116.7m
-20.99%
|
$114.2m
-2.15%
|
$101.3m
-11.29%
|
|
| Gross Profit | $44.2m |
$34.7m
-21.51%
|
$25.1m
-27.59%
|
$34.6m
+37.77%
|
$32.6m
-5.81%
|
$58.9m
+80.74%
|
$49.0m
-16.69%
|
$52.8m
+7.64%
|
$37.3m
-29.36%
|
$45.8m
+22.79%
|
$57.9m
+26.57%
|
|
| Research and Development Expense | $67.6m | $65.3m | $62.6m | $59.6m | $64.2m | $112.9m | $193.0m | $187.2m | $134.9m | $97.3m | $88.4m | |
| Selling, General and Administrative Expense | $47.8m | $59.1m | $63.5m | $75.5m | $72.8m | $124.1m | $160.9m | $169.8m | $175.0m | $141.5m | $129.7m | |
| Amortization of Intangible Assets | — | — | — | — | — | $400k | $900k | $6.2m | $27.4m | $369.4m | — | |
| Operating Expenses | $115.4m | $124.4m | $126.1m | $135.1m | $137.0m | $269.3m | $356.2m | $387.2m | $511.6m | $599.6m | $322.7m | |
| Operating Income (Loss) | ($71.2m) |
($89.8m)
-26.02%
|
($101.0m)
-12.48%
|
($100.5m)
+0.44%
|
($104.4m)
-3.82%
|
($210.4m)
-101.60%
|
($307.2m)
-45.98%
|
($334.5m)
-8.88%
|
($474.3m)
-41.81%
|
($553.9m)
-16.77%
|
($163.4m)
+70.49%
|
|
| Interest Expense, Debt | — | — | — | — | — | $12.3m | $14.1m | — | — | — | $7.3m | |
| Investment Income, Net | — | — | — | — | — | — | — | $32.8m | $24.9m | $13.1m | — | |
| Other Nonoperating Income (Expense) | $103k | $516k | $848k | $1.0m | $2.1m | $93k | $7.6m | $32.7m | $23.8m | $14.8m | — | |
| Interest Expense (non-operating) | $3.2m | $2.9m | $2.4m | $2.6m | $267k | $12.5m | $14.7m | $14.3m | $13.4m | $7.0m | $7.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | ($103.1m) | ($84.8m) | $28.9m | ($275.4m) | ($315.7m) | ($318.9m) | ($311.0m) | ($547.5m) | ($130.6m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $84.1m | $29.4m | ($274.9m) | ($314.2m) | ($318.2m) | ($309.5m) | ($546.1m) | ($130.6m) | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | $0 | $0 | $521k | $864k | $827k | |
| Income Tax Expense (Benefit) | — | — | — | — | — | ($93.6m) | $0 | ($11.4m) | $316k | $318k | $827k | |
| Net Income (Loss) Attributable to Parent | ($74.4m) |
($92.2m)
-23.95%
|
($102.6m)
-11.25%
|
($84.1m)
+17.97%
|
$29.4m
+134.95%
|
($181.2m)
-716.34%
|
($314.2m)
-73.40%
|
($306.7m)
+2.39%
|
($309.9m)
-1.02%
|
($546.4m)
-76.34%
|
($131.4m)
+75.95%
|
|
| Earnings Per Share, Basic | — | — | ($0.76) | ($0.55) | $0.18 | ($0.89) | ($1.40) | ($1.21) | ($1.13) | ($1.82) | ($0.42) | |
| Earnings Per Share, Diluted | — | — | — | — | $0.17 | ($0.89) | ($1.40) | ($1.21) | ($1.59) | ($1.82) | ($0.42) | |
| Common Stock, Dividends, Per Share, Declared | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 165.2m | 204.1m | 224.6m | 253.6m | 274.5m | 300.0m | 304.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 175.0m | 204.1m | 224.6m | 253.6m | 288.4m | 300.0m | 304.8m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | — | — | — | — | — | $31.1m | — | $9.0m | $0 | $0 | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | — | $144.5m | — | $93.2m |